Data / Form D filings / Biscayne Pharmaceuticals Inc.
Biscayne Pharmaceuticals Inc.: Form D filings
Biscayne Pharmaceuticals Inc., a pharmaceuticals company in Miami, FL, filed 3 Form D notices with the SEC between 2013 and 2015. The latest, on November 4, 2015, reports $609,000 sold of a $2 million offering to 3 investors.
Find out what Biscayne Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4770 BISCAYNE BLVD., SUITE 660, Miami, FL, 33137
- Phone
- (305) 505-0974
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Florida
- Year incorporated
- 2012
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1567845
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2015 | New notice | $2,000,000 | $609,000 | $1,391,000 | 3 | Oct 23, 2015 | sec.gov |
| May 1, 2014 | New notice | $6,000,000 | $2,628,000 | $3,372,000 | 23 | Apr 11, 2014 | sec.gov |
| Jan 25, 2013 | New notice | $1,500,000 | $1,500,000 | $0 | 6 | Jan 8, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen D. Collins | Executive Officer | |
| Jack J. Levine | Director | |
| Samuel J. Reich | Executive Officer, Director | |
| Norman J. Block | Director | |
| Warren J. Lammert | Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Nov 2, 2015 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Biscayne Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.